Report Phase 2 OLE 52-week data update for ESK-001 in plaque psoriasis
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 6 Feb 2025
- Due
- 31 Dec 2025
- Delivered
- 8 Mar 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Alumis expects a Phase 2 OLE 52-week data update in PsO in 2025”
What we found
Evidence strength A What the grades mean
Alumis reported full 52-week Phase 2 OLE data for ESK-001 in plaque psoriasis at the AAD Annual Meeting on March 8, 2025, well within the 2025 target.
-
A Late-Breaking ESK-001 Phase 2 OLE Data Presented at 2025 AAD Annual Meeting SEC 8-K exhibit announcing 52-week OLE data presentation
-
A ALUMIS INC. - Form 8-K - FY2025 (Year End 2024 Results) Confirms 52-week psoriasis data presented at AAD 2025
-
B Late-Breaking ESK-001 Phase 2 OLE Data Presented at 2025 AAD Annual Meeting Demonstrate Robust Clinical Responses Over 52-Weeks in Psoriasis Company press release confirming 52-week OLE data release
Checked 14 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Language
- Expected (“expects”, “plans”)
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Alumis Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-ALMS-000344 · Corrections policy